Succesful use of theoretically calculated dosage of sugammadex for routine reversal of vecuronium-induced muscle relaxation
Keywords:
rocuronium, TOF, dosage, muscle relaxation, BridionAbstract
Background: Sugamadex (Bridion) is a new drug that neutralizes neuromuscular block caused by amniosteroidal muscle relaxants. The data about exact dosage of sugamadex for routine neutralization of neuromuscular block caused by vecuronium is scarce as the number of trails regrading the use of sugamadex to neutralize neuromuscular block caused by vecuronium are very limited. Patients and methods: In this article we report two patients in whom muscular relaxation was induced by vecuronium for the purpose of general anesthesia for scheduled abdominal surgery. At the end of surgery muscle relaxation was neutralised with sugamadex with vecuronium dosege adjusted according to our theoretical calculations. In both cases we used sigificantly smaller dosages of sugmmadex than recommended by the manufacturer. We discuss why would these theoretically calculated dosages be sufficient for routine reversal of vecuroniuminduced muscle relaxation. Conclusion: In both cases we achieved complete reversal of vecuronium induced muscle relaxation with theoretically ajusted dosage of sugamadex.Downloads
Downloads
Published
Issue
Section
License
The Author transfers to the Publisher (Slovenian Medical Association) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Slovenian Medical Association) has the right to transfer the rights of acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.
